RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Intercept Pharmaceuticals Stock

Intercept Pharmaceuticals ROCE 2024

Intercept Pharmaceuticals ROCE

-0.73

Ticker

ICPT

ISIN

US45845P1084

WKN

A1J5U0

In 2024, Intercept Pharmaceuticals's return on capital employed (ROCE) was -0.73, a -233.9% increase from the 0.55 ROCE in the previous year.

Intercept Pharmaceuticals Aktienanalyse

What does Intercept Pharmaceuticals do?

Intercept Pharmaceuticals Inc is a biotechnology company based in New York City that focuses on the discovery and development of therapeutics for the treatment of chronic liver diseases. The company was founded in 2002 and has since brought a variety of innovative drugs to the market. The business model of Intercept Pharmaceuticals Inc is based on the invention, development, and marketing of drugs that specifically target certain disease conditions. They primarily focus on the development of drugs for the treatment of non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). These two diseases are prevalent worldwide and pose significant health problems in many Western societies. Intercept Pharmaceuticals Inc has already achieved significant success in the treatment of NAFLD and NASH. The various divisions of Intercept Pharmaceuticals Inc can be divided into research, development of new products, sale of existing drugs, and collaboration with partners and other companies. In research, the company strives to develop the most effective and safe medications, utilizing state-of-the-art technologies and research methods. The main products of Intercept Pharmaceuticals Inc are Ocaliva and obeticholic acid. Ocaliva is a medication used to treat primary biliary cholangitis, a disease that causes inadequate movement of bile through the liver and its accumulation in the body. Ocaliva helps improve bile production and alleviate the symptoms of this disease. Obeticholic acid is a new approach to the treatment of NASH and is currently being tested in clinical trials. Intercept Pharmaceuticals Inc works closely with other companies and organizations to ensure the most effective therapy for patients worldwide. Interaction with industry colleagues, scientific institutions, and experts in the field of medical research allows for faster development of new products that benefit patients. Overall, Intercept Pharmaceuticals Inc has achieved an impressive track record in recent years. The company has established a strong position in the field of liver diseases by advancing research and development in innovative ways. The focus on NAFLD and NASH allows Intercept Pharmaceuticals Inc to play a leading role in this market segment and provide patients with effective medications for their conditions. In summary, Intercept Pharmaceuticals Inc is a company dedicated to the development and marketing of products for the treatment of liver diseases. Through the use of innovative technologies and close collaboration with other companies and organizations, Intercept Pharmaceuticals Inc has already achieved significant success in the development of new medications. The company has established a strong position in this market segment and aims to develop further innovative products to combat liver diseases in the future. Intercept Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Intercept Pharmaceuticals's Return on Capital Employed (ROCE)

Intercept Pharmaceuticals's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Intercept Pharmaceuticals's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Intercept Pharmaceuticals's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Intercept Pharmaceuticals’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Intercept Pharmaceuticals stock

What is the ROCE (Return on Capital Employed) of Intercept Pharmaceuticals this year?

The ROCE of Intercept Pharmaceuticals is -0.73 undefined this year.

How has the ROCE (Return on Capital Employed) of Intercept Pharmaceuticals developed compared to the previous year?

The ROCE of Intercept Pharmaceuticals has increased by -233.9% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Intercept Pharmaceuticals?

A high Return on Capital Employed (ROCE) indicates that Intercept Pharmaceuticals has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Intercept Pharmaceuticals?

A low ROCE (Return on Capital Employed) can indicate that Intercept Pharmaceuticals has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Intercept Pharmaceuticals impact the company?

An increase in the ROCE of Intercept Pharmaceuticals can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Intercept Pharmaceuticals affect the company?

A decrease in ROCE of Intercept Pharmaceuticals can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Intercept Pharmaceuticals?

Some factors that can affect Intercept Pharmaceuticals's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Intercept Pharmaceuticals so important for investors?

The ROCE of Intercept Pharmaceuticals is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Intercept Pharmaceuticals take to improve the ROCE?

To improve the ROCE, Intercept Pharmaceuticals can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Intercept Pharmaceuticals pay?

Over the past 12 months, Intercept Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Intercept Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Intercept Pharmaceuticals?

The current dividend yield of Intercept Pharmaceuticals is .

When does Intercept Pharmaceuticals pay dividends?

Intercept Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Intercept Pharmaceuticals?

Intercept Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Intercept Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Intercept Pharmaceuticals located?

Intercept Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Intercept Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Intercept Pharmaceuticals from 10/9/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/9/2024.

When did Intercept Pharmaceuticals pay the last dividend?

The last dividend was paid out on 10/9/2024.

What was the dividend of Intercept Pharmaceuticals in the year 2023?

In the year 2023, Intercept Pharmaceuticals distributed 0 USD as dividends.

In which currency does Intercept Pharmaceuticals pay out the dividend?

The dividends of Intercept Pharmaceuticals are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Intercept Pharmaceuticals stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Intercept Pharmaceuticals

Our stock analysis for Intercept Pharmaceuticals Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Intercept Pharmaceuticals Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.